• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.33% Nasdaq Down 0.24%

    Agios Pharmaceuticals, Inc. (AGIO)

    -NasdaqGS
    124.04 Up 0.81(0.66%) 12:21PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:123.23
    Open:122.89
    Bid:123.81 x 300
    Ask:123.96 x 100
    1y Target Est:124.25
    Beta:1.979
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:120.47 - 124.60
    52wk Range:32.66 - 138.85
    Volume:321,124
    Avg Vol (3m):634,223
    Market Cap:4.63B
    P/E (ttm):N/A
    EPS (ttm):-1.32
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AGIO

    Comparison

    Symbol% ChgMkt Cap
    AGIOUp 0.66%4.63B
    ALXNDown 1.60%33.02B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):50.32
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.09
    Quarterly EPS Est (Jun-15) :-0.50
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Agios Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics in the field of cancer metabolism and rare genetic disorders of metabolism in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback